Extract of regimen rankings for efficacy in preventing active TB and causing lowest rates of adverse events.
| Ranking (95% CrI) | ||
|---|---|---|
| Regimen | Active TB | Adverse events |
| Isoniazid ≤4 months | 11 (6, 13) | 11 (10, 11) |
| Isoniazid 6 months | 8 (5, 11) | 5 (3, 8) |
| Isoniazid 9 months | 11 (4, 14) | 7 (4, 9) |
| Isoniazid ≥12 months | 6 (4, 9) | 7 (4, 9) |
| Rifampicin/Isoniazid ≥3 months | 7 (4, 10) | 4 (3, 7) |